Hou D Y, Maruyama Y
Department of Radiation Medicine, University of Kentucky Medical Center, Lexington.
J Surg Oncol. 1992 Feb;49(2):93-7. doi: 10.1002/jso.2930490206.
The distribution of 111In-bleomycin Complex (111In-BLMC) in small cell lung cancer (SCLC) cells was studied by autoradiography. SCLC cells were exposed to 111In-BLMC and 111Indium chloride (111InCl3) for 1 hour, 3 hours, and 4 hours; washed with fresh medium; and spread on slides. The slides were smeared with NTB2 (NTB3) emulsion by wet or dry-mount technique and exposed 3 to 15 days. 111In-BLMC was found to localize in the cell nucleus and nuclear membrane (78.3%); 111InCl3 located mainly in the cytoplasm (52.3%). This distribution of labeled BLM may explain the mechanism of killing SCLC cells by 111In-BLMC.
通过放射自显影术研究了铟-博来霉素复合物(¹¹¹In-BLMC)在小细胞肺癌(SCLC)细胞中的分布。将SCLC细胞分别暴露于¹¹¹In-BLMC和氯化铟(¹¹¹InCl₃)1小时、3小时和4小时;用新鲜培养基洗涤;然后铺在载玻片上。通过湿装或干装技术将载玻片涂上NTB2(NTB3)乳剂,并曝光3至15天。发现¹¹¹In-BLMC定位于细胞核和核膜(78.3%);¹¹¹InCl₃主要位于细胞质(52.3%)。标记博来霉素的这种分布可能解释了¹¹¹In-BLMC杀死SCLC细胞的机制。